
The importance of early detection
Breast cancer is the most common cancer diagnosed among women in the United States, and finding it early can be the difference between life and death.
Breast cancer that is found early and has not spread is easier to treat successfully. CHRISTUS Health emphasizes the importance of early detection and provides resources, procedures and screenings.
A reliable way to find breast cancer in the early stages is through regular screenings.
“Breast cancer is one of the few cancers where we have screening guidelines because we know we can catch it early and cure the patient, essentially by getting rid of the tumor,” said Dr. Deepika Ralla, hematologist and oncologist at
CHRISTUS Highland Medical Center in Shreveport and Bossier Cancer
Center. “I don’t want to overemphasize the word ‘cure,’ but if you catch
it early, the survival rate is very good.”
Ralla stressed the importance of mammogram screening, an effective tool for early detection of breast cancer.
In
addition to traditional mammography, CHRISTUS Health also offers 3D
mammography, which is more advanced. A 3D screening captures multiple
X-ray images from different angles. The images are reconstructed into a
3D representation of the breast tissue, offering advantages over traditional 2D images.
“The pictures are more clear,” Ralla said.
“It’s a better version of looking at the breast tissue to clearly find abnormalities and to see if it’s really abnormal.”
However, Ralla said not all breast cancers are found on a mammogram.
“If
you feel a lump and your mammogram is negative, be sure to talk to your
doctor because you may need an ultrasound,” she said. “Some cancers are
mammogram negative so they might need an ultrasound, an MRI, an
evaluation by a surgeon or a biopsy.”
According
to the National Breast Cancer Foundation, 1 in 8 women in the United
States will be diagnosed with breast cancer in her lifetime. In 2024, an
estimated 310,720 women and 2,800 men will be diagnosed with invasive
breast cancer.
When caught early, the five-year survival rate for women with localized breast cancer is 99%.
“For
early stage, hormone-positive breast cancer, the survival rate is good.
But you’re talking about the typical standard breast cancer, the one
that feeds on hormones,” Ralla said. “As the stage advances and gets
into the lymph nodes, the more lymph nodes involved, the higher chance
of the tumor coming back, despite chemotherapy, radiation or hormone
therapy.”
Although not always present, breast cancer symptoms can include:
• a lump or mass in the breast
• change in skin texture
• nipple puckering or discharge
• swelling or thickness in part of the breast
• tenderness
• breast or nipple pain
• change in size or shape of the breast.
“But
without any of these symptoms, I would recommend being aware of how
your breasts normally feel,” Ralla said. “If there is a lump in the
armpit, that is also related to the breast.”
CHRISTUS Health offers an excellent breast cancer screening program, Ralla said.
“They
don’t just do the mammogram and let the patient go,” she said. “They
follow up on any positive test. Sometimes they may need radiation and
pictures and sometimes they may need a biopsy. So, that step is already
built into the process.”
National guidelines for breast cancer screening recommend women with average risk to start screening at 40 years old.
“That
includes someone with no family history of breast cancer and without a
known breast cancer mutation in their genes,” Ralla said. “But if you
have a family history of breast cancer, then it would be earlier.”
Treatment options after a breast cancer diagnosis include surgery, radiation and chemotherapy.
“If
it’s just the tumor that’s taken out during surgery, then radiation and
hormone blocking therapy is usually done to prevent the cancer from
coming back,” Ralla said. “If it’s high risk, then they may need
chemotherapy followed by surgery and radiation. It depends on the stage;
it’s not generalized, it’s custom tailored.”
To learn more about CHRISTUS Health and breast cancer screening, visit their website at CHRISTUSHealth.org.
Dr. Deepika Ralla is a hematologist and oncologist at CHRISTUS Highland Medical Center in Shreveport and Bossier Cancer Center.